In light of recently announced major biotech acquisitions - Dicerna (NASDAQ: DRNA) was acquired by Novo Nordisk (NYSE ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments FDA Mergers and Acquisitions Trader Talk

Pfizer (PFE) Announces FDA Approval of XELJANZ for the Treatment of Active Ankylosing SpondylitisDecember 14, 2021 4:08 PM UBS Upgrades Pfizer (PFE) to Buy, Downgrades Merck (MRK) to NeutralDecember 13, 2021 9:51 AM Pfizer’s (PFE) $6.7B Arena Acquisition is Priced Reasonably, May Offer Additional Upside, Pfizer Making Good Use of Cash – AnalystDecember 13, 2021 9:30 AM Pfizer (PFE) to Buy Arena Pharmaceuticals (ARNA) in a $6.7 Billion Deal, Pays a 100% Premium; Seen as the First of Many AcquisitionsDecember 13, 2021 6:41 AM Pfizer bets on Arena's promising bowel disease treatment in $6.7 billion dealDecember 13, 2021 6:33 AM Pfizer (PFE) to Acquire Arena Pharmaceuticals (ARNA) for $100 Per Share, $6.7 Billion DealDecember 13, 2021 6:11 AM Sangamo Therapeutics (SGMO) and Pfizer (PFE) Announce Updated Phase 1/2 Results Showing Sustained Bleeding Control in Highest Dose Cohort Through Two Years Following Hemophilia A Gene TherapyDecember 13, 2021 5:04 AM UPDATE: UBS Upgrades Pfizer (PFE) to BuyDecember 13, 2021 3:53 AM Pfizer (PFE) Raises Quarterly Dividend 2.6% to $0.40; 3% YieldDecember 10, 2021 12:01 PM Boosters give 70-75% Omicron protection, U.K. study shows - BloombergDecember 10, 2021 11:46 AM Pfizer's (PFE) Cibinqo Approved in EU for Treatment of Adults with Moderate-to-Severe Atopic DermatitisDecember 10, 2021 9:27 AM Arvinas Inc. (ARVN) and Pfizer (PFE) Announce PROTAC Protein Degrader ARV-471 Continues to Demonstrate Encouraging Clinical Benefit Rate in Patients with Locally Advanced or Metastatic ER+/HER2- BreasDecember 10, 2021 8:12 AM Pfizer (PFE) PT Raised to $54 at BarclaysDecember 10, 2021 4:36 AM CDC Expands Booster Recommendations To 16-and-17-year-olds - BloombergDecember 9, 2021 2:30 PM